These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 5010464)
1. Measurement of immunity following live mumps (5 years), measles (3 years), and rubella (2 and one-half years) virus vaccines. Weibel RE; Buynak EB; Stokes J; Hilleman MR Pediatrics; 1972 Mar; 49(3):334-41. PubMed ID: 5010464 [No Abstract] [Full Text] [Related]
2. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines. Weibel RE; Buynak EB; Stokes J; Hilleman MR Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864 [No Abstract] [Full Text] [Related]
3. Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines. Weibel RE; Buynak EB; McLean AA; Hilleman MR Pediatrics; 1975 Sep; 56(3):380-7. PubMed ID: 1161394 [TBL] [Abstract][Full Text] [Related]
4. The timing of tuberculin tests in relation to immunization with live viral vaccines. Brickman HF; Beaudry PH; Marks MI Pediatrics; 1975 Mar; 55(3):392-6. PubMed ID: 1143978 [TBL] [Abstract][Full Text] [Related]
5. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella. Nasibov MN; Yakovleva NV; Smorodintsev AA Prog Immunobiol Stand; 1970; 4():676-82. PubMed ID: 5482205 [No Abstract] [Full Text] [Related]
7. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC; Burgess MA; O'Brien ED Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
8. Recommendation of the Public Health Service Advisory Committee on Immunization Practices. Combination live virus vaccines: measles and rubella measles, mumps and rubella. J Kans Med Soc; 1971 Oct; 72(10):428 passim. PubMed ID: 5109988 [No Abstract] [Full Text] [Related]
10. Topics in clinical medicine. New vaccines against viral diseases: mumps, rubella, and measles. Seto DS; Carver DH Johns Hopkins Med J; 1969 Apr; 124(4):231-7. PubMed ID: 5774148 [No Abstract] [Full Text] [Related]
11. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. King SM; Saunders EF; Petric M; Gold R Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367 [TBL] [Abstract][Full Text] [Related]
12. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
13. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E; Tischer A Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543 [TBL] [Abstract][Full Text] [Related]
15. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps. Rose VL Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963 [No Abstract] [Full Text] [Related]
16. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA Clin Immunol; 2005 May; 115(2):154-61. PubMed ID: 15885638 [TBL] [Abstract][Full Text] [Related]
17. Studies on live rubella vaccine. II. Field trials with two experimental vaccine strains. Minekawa Y; Suzuki N; Takahashi M; Okuno Y Biken J; 1968 Dec; 11(4):243-50. PubMed ID: 5721530 [No Abstract] [Full Text] [Related]
18. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population]. Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596 [TBL] [Abstract][Full Text] [Related]
19. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella. Heath TC; Burgess MA; Forrest JM Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550 [No Abstract] [Full Text] [Related]